Arkolith/Insider Trading/NEUP/Form 4/A

Papapetropoulos Spyros

President and CEO, DirectorNeuphoria Therapeutics Inc. (NEUP) · full profile →Form 4/A · filed May 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 16, 2025Grant(A)27K$5.16$139K40K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001213900-25-045445) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML